Dr. Brit Mollenhauer of Paracelsus-Elena-Klinik was a researcher in BIOMARKAPD, a JPND project on biomarkers for Alzheimer’s disease and Parkinson’s disease that ran from 2012-2015.
In an interview with JPND, she reflects on the project and discusses the importance of biomarkers for research into Parkinson’s disease:
Prof. Gunhild Waldemar of Rigshospitalet and Copenhagen University participated in BIOMARKAPD, a JPND project on biomarkers for Alzheimer’s disease and Parkinson’s disease that ran from 2012-2015.
She spoke with JPND about the importance of biomarkers for research into neurodegenerative diseases, her hopes for the field, and advice she would give to early-career researchers.
Dr. Charlotte Teunissen of the VU University Medical Center in Amsterdam was a work package leader for BIOMARKAPD, a JPND project on biomarkers for Alzheimer’s disease and Parkinson’s disease that ran from 2012-2015.
In an interview with JPND, she reflects on the project and discusses the importance of biomarkers for research into neurodegenerative diseases:
Professor Judes Poirier of McGill University and the Douglas Institute in Montreal, Canada, was a participant in BIOMARKAPD, a JPND project on biomarkers for Alzheimer’s disease and Parkinson’s disease that ran from 2012-2015.
In an interview with JPND, he expounds on how advancements in the biomarkers field, combined with genetics, is bringing tremendous change to the study of Alzheimer’s disease and Parkinson’s disease.